Literature DB >> 5573604

Progestogen treatment of recurrent endometrial carcinoma.

G D Malkasian, D G Decker, E Mussey, C E Johnson.   

Abstract

Entities:  

Keywords:  Biology; Cancer; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Progestin; Contraceptive Agents--administraction and dosage; Contraceptive Methods--administraction and dosage; Depo-provera--administraction and dosage; Diseases; Endocrine System; Endometrial Cancer; Family Planning; Hormones; Injectables--administraction and dosage; Medrogestone--administraction and dosage; Medroxyprogesterone Acetate--administraction and dosage; Neoplasms; Oral Contraceptives; Physiology; Progestational Hormones; Research Methodology

Mesh：

Substances：

Year:  1971        PMID： 5573604     DOI： 10.1016/0002-9378(71)90207-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  4 in total

Review 1.  Steroid hormone receptors in the regulation of differentiation. A review.

Authors:  K S McCarty; K S McCarty
Journal:  Am J Pathol       Date:  1977-03       Impact factor: 4.307

2.  [Influencing of mitosis rate in endometrial carcinomas using 17-hydroxynorprogesterone capronate in women].

Authors:  R Kaiser; E Schneider
Journal:  Arch Gynakol       Date:  1972

3.  [Effect of gestagen therapy upon estradiol- and progesterone-receptor-level and 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma (author's transl)].

Authors:  K Pollow; E Boquoi
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30

4.  Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.

Authors:  K S McCarty; T K Barton; B F Fetter; W T Creasman; K S McCarty
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.